Tuyển tập các báo cáo nghiên cứu về sinh học được đăng trên tạp chí hóa học quốc tế đề tài : Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial | BioMed Central Health and Quality of Life Outcomes Research Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial Muriel Viala-Danten 1 Susan Martin2 Isabelle Guillemin1 and Ron D Hays3 Address 1Mapi Values 19 rue de la Villette 69003 Lyon France 2Pfizer 2800 Plymouth Road Ann Arbor MI 48105 USA and 3UCLA Department of Medicine Division of General Internal Medicine Health Services Research 911 Broxton Avenue Room 110 Los Angeles CA 90024-2801 USA Email Muriel Viala-Danten - mviala@ Susan Martin - smartin321@ Isabelle Guillemin - iguillemin@ Ron D Hays - drhays@ Corresponding author Open Access Published 17 December 2008 Received 19 May 2008 I. J zv z. z . nn zn-mrir z I I Accepted 17 December 2008 Health and Quality of Life Outcomes 2008 6 113 doi l477-7525-6-113 This article is available from http content 6 1 1 13 2008 Viala-Danten et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Sleep is an important element of functioning and well-being. The Medical Outcomes Study Sleep Scale MOS-Sleep includes 12 items assessing sleep disturbance sleep adequacy somnolence quantity of sleep snoring and awakening short of breath or with a headache. A sleep problems index grouping items from each of the former domains is also available. This study evaluates the psychometric properties of MOS-Sleep Scale in a painful diabetic peripheral neuropathic population based on a clinical trial conducted in six countries. Methods Clinical data and health-related quality of life data were collected at baseline and after 12 weeks of follow-up. .
